Expert advice
Medicines management: Why must co-dydramol now be prescribed by strength rather than number of tablets?
With new co-dydramol products now available with a higher strength of opioid analgesic dihydrocodeine, prescribing and dispensing them by strength is vital to ensure patient safety and minimise the risk of accidental opiate overdose, says medicines management expert Matt Griffiths
This article is for subscribers only
Read this journal via your Institutional access
SIGN IN
Read this journal via your Institutional accessLatest podcasts
Anne Marie Rafferty: RCN president’s tips...
20 Dec 2018
From Jamaica to the UK: my experiences as...
03 Oct 2018
Childhood obesity: my vision for...
19 Sep 2018
5 Most Read Articles
Readers’ panel: Should nurses be allowed to take naps on night shifts?
The Health Foundation is funding research on support for staff working night shifts
15 Feb 2019
The best way to beat bullies at work
Bullying and harassment are a problem in the NHS, but there are strategies to help you cope
18 Feb 2019
Transcribing: what the new medicines management guidance states
Royal Pharmaceutical Society and RCN publish document on transcribing information
06 Feb 2019
Three minutes to save a life: the course designed to raise suicide awareness
University initiative aims to equip all staff and students to support people at risk
19 Feb 2019
What you need to know about the new NMC code of conduct
The revised Code contains the professional standards that registered nurses and midwives...
01 Mar 2015